Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 3 Acceptability

From: Single-dose intravenous ketamine or intramuscular naltrexone for high-utilization inpatients with alcohol use disorder: pilot trial feasibility and readmission rates

 

Arm 1 KET

Arm 2 NTX

Arm 3 LA

Int (n = 12)*

FU (n = 6)

Int (n = 12)**

FU (n = 5)

Int (n = 17)

FU (n = 6)***

Acceptability of intervention, Likert 1–10: mean (sd)

9.5 (0.80)

9.5 (1.22)

9.17 (1.40)

8.67 (2.13)

  

Effectiveness of intervention, Likert 1–10: mean (sd)

8.75 (1.48)

7.67 (3.61)

7.75 (2.34)

7.5 (2.06)

  

Motivation of financial incentive, Likert 1–10: mean (sd)

2.42 (2.84)

4.00 (3.35)

4.46 (3.40)

4.17 (3.08)

2.5 (2.76)

4.33 (3.67

  1. *1 participant did not receive intervention
  2. **2 participants did not receive intervention
  3. ***7 participants provided some data, only 6 provided data listed in this table
Back to article page

Addiction Science & Clinical Practice

ISSN: 1940-0640